Sunday, January 27, 2013

Why It May Be Time to Consider Actos Litigation

Have Actos Dangers Changed Your Life?

The diabetic drug, Actos, gained FDA approval over thirteen years ago. Actos was approved specifically for the treatment of Type 2 diabetes. Avandia, a drug which was approved for the treatment of Type 2 diabetes at roughly the same time fell under scrutiny in 2009 and 2010, leaving Actos as the primary drug of choice when doctors were prescribing for their Type 2 diabetes patients. Unfortunately, adverse reports regarding Actos soon began coming to light.

Despite these negative reports, the sales of Actos continued to skyrocket with its manufacturer, Takeda, netting over $3 billion dollars for the sale of Actos in 2010 alone. While it is believed that the potential of Actos to cause cancer in rats was well-known at the time of its release in 1999, it was not until after 2005 that the drug’s potential risks of bladder cancer began to come to light. When a large number of Actos patients were found to have developed bladder cancer, research was undertaken which eventually showed that the increase in risk of bladder cancer could be as high as 40% among Actos users.

An Actos clinical trial studied over 10,000 Type 2 diabetic patients who were being treated with Actos and these trials showed definitive correlation between the drug, congestive heart failure and an increased risk of bladder cancer. While Actos has been pulled from the French and German markets, the U.S. FDA is still considering a recall while they review safety concerns. While bladder cancer—if caught early—is treatable, there is a high recurrence of this type of cancer. Some of the symptoms of bladder cancer include blood in the urine, frequent urination or pain during urination and the need to urinate with no results. Should your bladder cancer progress to later stages before it is diagnosed, the results can be much more serious and life-altering.

Why Actos Litigation May Be the Right Choice for You

FDA approval of Actos took place in less than three months—near record time for a prescription drug. Many believe that Takeda was well aware of the risks related to Actos, yet continued to market the drug for many years. Attorneys associated with Actos-related litigation generally believe there was an overall failure to warn, however there is a causation factor to consider as well. Bladder cancer is more common in those over sixty, those who smoke, those who are obese, those with a history of high blood pressure and those who are regularly exposed to toxic chemicals such as asbestos. For unknown reasons, men are almost five times as likely to be victims of kidney cancer. Despite these causation factors, the research regarding Actos still points strongly to the drug as a potential risk in the development of kidney cancer, and the longer a person takes the drug, the higher their risk becomes.

How Actos Lawyers Can Help

The first Actos lawsuit was filed in 2011 by a victim who took Actos and will likely end up having her bladder removed—and will be subjected to extended radiation and chemotherapy. It is yet undetermined if Takeda was lax in conducting complete testing of the side effects of Actos prior to its release. Although Actos currently displays a black box warning, no recall is on the horizon and those who feel they have been harmed by the drug may want to consider whether the Actos dangers warrant litigation.

Author: Sullo & Sullo Attorneys

0 Comments

Categories: ImportedNumber of views: 1711

Tags: actos Attorny actos bladder cancer actos claims Actos Damages actos fda warning actos heart failure actos kidney disease actos law firm actos lawsuits actos recalls europe

Please login or register to post comments.

250,000 CLIENTS REPRESENTED

FREE CASE REVIEW

Full Name* Email* Telephone Number* Are You already a Client?* Type of Case* Tell Us About Your Case*

WARNING: Do not send any information in any email through this website if you consider the information confidential or privileged.

I understand that by submitting my contact information to Sullo & Sullo LLP for review, I consent to messages regarding this legal matter as well as marketing for other potential legal matters in the future without limitation at standard messaging and data rates unless terminated by me in writing. I further understand that my submission of any and all information in response to this website does NOT create a lawyer-client relationship between myself and Sullo & Sullo, LLP and/or its lawyers, and that any and all information submitted is NOT confidential or privileged. I further acknowledge that, unless Sullo & Sullo, LLP subsequently enters into an Attorney-Client relationship with me, any and all information I provide will NOT be treated as confidential or privileged, and any such information may be used against me and/or for the benefit of current or future clients of Sullo & Sullo, LLP. ...READ ENTIRE DISCLAIMER

Receive an Immediate Response

ANDREW SULLO IS A TOP 100 NATIONAL TRIAL LAWYER 2013 • 2014 • 2015 • 2016 • 2017 • 2018 • 2019

Obtener una Respuesta Inmediata

Andrew Sullo – 100 Mejores Abogados Nacional | 2013 • 2014 • 2015 • 2016 • 2017